The director of the Biomedical Advanced Research and Development Authority has launched two new funding programs in the past three years.
The organizations noted in a letter to HHS and FDA that they "believe the agency's actions may in fact inflict greater harm on patients and impede innovation."
The award will fund optimization of the Hemopurifier exosome isolator, with an eye towards developing applications in cancer research and clinical care.
The company decided to settle the complaint in order to avoid "lengthy and distracting litigation," but denies any wrongdoing.
US health officials have issued a fraud alert for a scam involving genetic testing, Bloomberg reports.
The Trump Administration has curbed fetal tissue research in the US, the New York Times reports.
Proposals from two HHS agencies look to encourage patient access to data and interoperability in research and clinical practice, including Sync for Genes.
ScienceInsider reports that some risky flu studies that came to a halt a few years back may soon resume.
The National Institutes of Health has asked a federal oversight office to review a dozen allegations of foreign influence on US research, Stat News reports.
The RT-qPCR-based assay, which has 510(k) clearance, is designed to rapidly differentiate sepsis from systemic inflammatory response syndrome.
Russian CRISPR researcher moves along with plans to ultimately alter the genes of embryos of deaf couples, though awaits regulatory approval, Nature News reports.
University of California, San Francisco, researchers have uncovered a gene mutations that appears to make a father-son duo more efficient sleepers.
NPR reports a large health insurer has begun to cover some pharmacogenetic tests for psychiatric drugs.
In PLOS this week: genome-wide association study of non-syndromic orofacial cleft subtypes, epigenetic and transcriptomic analysis of pancreatic ductal adenocarcinoma, and more.